Economic Assessment of Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease
Compared with ipratropium alone, fluticasone/salmeterol combination therapy resulted in better clinical outcomes and similar or lower treatment costs in all COPD populations studied.